Correlation Between Snap and Integrated Biopharma
Can any of the company-specific risk be diversified away by investing in both Snap and Integrated Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Snap and Integrated Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Snap Inc and Integrated Biopharma, you can compare the effects of market volatilities on Snap and Integrated Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Snap with a short position of Integrated Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Snap and Integrated Biopharma.
Diversification Opportunities for Snap and Integrated Biopharma
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Snap and Integrated is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Snap Inc and Integrated Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Biopharma and Snap is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Snap Inc are associated (or correlated) with Integrated Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Biopharma has no effect on the direction of Snap i.e., Snap and Integrated Biopharma go up and down completely randomly.
Pair Corralation between Snap and Integrated Biopharma
Given the investment horizon of 90 days Snap Inc is expected to generate 0.92 times more return on investment than Integrated Biopharma. However, Snap Inc is 1.09 times less risky than Integrated Biopharma. It trades about 0.04 of its potential returns per unit of risk. Integrated Biopharma is currently generating about -0.02 per unit of risk. If you would invest 791.00 in Snap Inc on August 26, 2024 and sell it today you would earn a total of 351.00 from holding Snap Inc or generate 44.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 13.96% |
| Values | Daily Returns |
Snap Inc vs. Integrated Biopharma
Performance |
| Timeline |
| Snap Inc |
| Integrated Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Snap and Integrated Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Snap and Integrated Biopharma
The main advantage of trading using opposite Snap and Integrated Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Snap position performs unexpectedly, Integrated Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Biopharma will offset losses from the drop in Integrated Biopharma's long position.The idea behind Snap Inc and Integrated Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Integrated Biopharma vs. Premier Foods Plc | Integrated Biopharma vs. Torque Lifestyle Brands | Integrated Biopharma vs. Naturally Splendid Enterprises | Integrated Biopharma vs. Aryzta AG PK |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |